Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
Status:
Terminated
Trial end date:
2008-08-01
Target enrollment:
Participant gender:
Summary
The purposes of this are:
- To determine the highest doses of Taxol and Navelbine that we can safely give to
patients;
- To determine what kind of side effects are caused by the combination of Taxol, Navelbine
and G-CSF;
- To determine whether the combination of Taxol, Navelbine and G-CSF is more effective
than standard therapy in treating metastatic breast cancer and prolonging life;